<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are an expert at identifying data availability statements in scientific text. A data availability statement describes where research data can be found or how it can be accessed.<|eot_id|><|start_header_id|>user<|end_header_id|>

Determine if the following text contains a data availability statement. Answer with 'yes' or 'no'.

Text: The findings from this systematic review highlight that EPA and DHA have differential effects on some cardiometabolic risk factors and that, to some degree, this effect is dependent on the study population. Both EPA and DHA are effective at lowering triglycerides, although there is evidence that DHA may lower triglycerides more than EPA. Whilst neither omega-3 PUFA alters total cholesterol to a great degree, DHA appears to increase HDL cholesterol, particularly the more cardioprotective HDL 2 subfraction, whilst EPA decreases HDL 3 cholesterol. DHA increases LDL cholesterol more than EPA, and more so in men than in women, and also increases LDL particle size, which may be less atherogenic. From the more limited trial **data** available, DHA may be more effective than EPA at lowering heart rate and blood pressure in normotensive individuals, whilst both EPA and DHA inhibited platelet function but had no effect on fibrinolytic function. Whilst inconsistent findings were reported for the effects of EPA and DHA on inflammatory markers and glycaemic control, both omega-3 PUFAs were able to lower oxidative stress, which is increased in certain subjects such as diabetics thereby increasing their risk of cardiovascular disease.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

yes<|eot_id|>